Current recommendations for revascularization of non-infarct-related artery in patients presenting with ST-segment elevation myocardial infarction and multivessel disease

被引:2
|
作者
Towashiraporn, Korakoth [1 ]
机构
[1] Mahidol Univ, Fac Med Siriraj Hosp, Her Majesty Cardiac Ctr, Bangkok, Thailand
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
关键词
ST-segment elevation myocardial infarction; multivessel disease; complete revascularization; percutaneous coronary intervention; infarct-related artery; PERCUTANEOUS CORONARY INTERVENTION; LESION-ONLY REVASCULARIZATION; CARDIOGENIC-SHOCK; SCIENTIFIC STATEMENT; RANDOMIZED-TRIAL; CULPRIT LESION; MANAGEMENT; PLAQUE; STEMI; OUTCOMES;
D O I
10.3389/fcvm.2022.969060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality worldwide. Immediate reperfusion therapy of the infarct-related artery (IRA) is the mainstay of treatment, either via primary percutaneous coronary intervention (PPCI) or thrombolytic therapy when PPCI is not feasible. Several studies have reported the incidence of multivessel disease (MVD) to be about 50% of total STEMI cases. This means that after successful PPCI of the IRA, residual lesion(s) of the non-IRA may persist. Unlike the atherosclerotic plaque of stable coronary artery disease, the residual obstructive lesion of the non-IRA contains a significantly higher prevalence of vulnerable plaques. Since these lesions are a strong predictor of acute coronary syndrome, if left untreated they are a possible cause of future adverse cardiovascular events. Percutaneous coronary intervention (PCI) of the obstructive lesion of the non-IRA to achieve complete revascularization (CR) is therefore preferable. Several major randomized controlled trials (RCTs) and meta-analyses demonstrated the clinical benefits of the CR strategy in the setting of STEMI with MVD, not only for enhancing survival but also for reducing unplanned revascularization. The CR strategy is now supported by recently published clinical practice guidelines. Nevertheless, the benefit of revascularization must be weighed against the risks from additional procedures.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Full Revascularization in the Patient With ST-Segment Elevation Myocardial Infarction The Story So Far
    Gershlick, Anthony H.
    Price, Matthew J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (22) : 2724 - 2727
  • [22] Infarct related artery only versus complete revascularization in ST-segment elevation myocardial infarction and multi vessel disease: a meta-analysis
    Vaidya, Satyanarayana R.
    Devarapally, Santhosh R.
    Arora, Sameer
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 (01) : 16 - 26
  • [23] Optimal timing of complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis
    Guo, Wen-Qin
    Li, Lang
    Su, Qiang
    Sun, Yu-Han
    Wang, Xian-Tao
    Dai, Wei-Ran
    Li, Hong-Qing
    CLINICAL EPIDEMIOLOGY, 2018, 10 : 1037 - 1051
  • [24] Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis
    Sanz-Sanchez, Jorge
    Chiarito, Mauro
    Regazzoli, Damiano
    Cannata, Francesco
    Condorelli, Gianluigi
    Reimers, Bernhard
    Stefanini, Giulio G.
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (12) : 988 - 990
  • [25] Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction
    Jensen, Lisette Okkels
    Terkelsen, Christian Juhl
    Horvath-Puho, Erzsebet
    Tilsted, Hans-Henrik
    Maeng, Michael
    Junker, Anders
    Lassen, Jens Flensted
    Thuesen, Leif
    Sorensen, Henrik Toft
    Thayssen, Per
    AMERICAN HEART JOURNAL, 2015, 170 (01) : 70 - 78
  • [26] Complete Revascularization of Multivessel Coronary Artery Disease Does Not Improve Clinical Outcome in ST-Segment Elevation Myocardial Infarction Patients with Reduced Left Ventricular Ejection Fraction
    Kang, Jeehoon
    Zheng, Chengbin
    Park, Kyung Woo
    Park, Jiesuck
    Rhee, Taemin
    Lee, Hak Seung
    Han, Jung-Kyu
    Yang, Han-Mo
    Kang, Hyun-Jae
    Koo, Bon-Kwon
    Kim, Hyo-Soo
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [27] Percutaneous coronary intervention strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease
    Thomas, Michael P.
    Bates, Eric R.
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (06) : 755 - 760
  • [28] Comprehensive Review of Complete Versus Culprit-only Revascularization for Multivessel Disease in ST-segment Elevation Myocardial Infarction
    Jacob, Robin
    Sachedina, Ayaaz K.
    Kumar, Sachin
    HEART INTERNATIONAL, 2021, 15 (01): : 54 - 59
  • [29] Oxidative Stress and Spontaneous Reperfusion of Infarct-Related Artery in Patients With ST-Segment Elevation Myocardial Infarction
    Borekci, Abdurrezzak
    Gur, Mustafa
    Turkoglu, Caner
    Selek, Sahbettin
    Baykan, Ahmet Oytun
    Seker, Taner
    Harbalioglu, Hazar
    Ozaltun, Betuel
    Makca, Ilyas
    Aksoy, Nurten
    Gozukara, Yavuz
    Cayli, Murat
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (02) : 171 - 177
  • [30] Effects of patient characteristics on the efficacy of complete revascularization for treatment of ST-segment elevation myocardial infarction with multivessel disease A meta-analysis
    Li, Lu-Feng
    Qiu, Mei
    Liu, Shu-Yan
    Zhou, Hai-Rong
    MEDICINE, 2021, 100 (25) : E26251